Clinical Trials Directory

Trials / Unknown

UnknownNCT03552094

World Mosquito Program Noumea - Human Sample Component

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Institut Pasteur · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The dengue, Zika and chikungunya arboviruses represent potentially severe infections to which the New Caledonian population is exposed. In the absence of specific treatment or vaccine, vector control remains the method of choice to limit their spread. However, the traditional methods of prevention and vector control measure today face their limits: mosquito resistance to insecticides, difficulty of access and destruction of breeding areas... The World Mosquito Program Noumea project is based on the artificial colonization of the mosquito vector Aedes aegypti by the endosymbiotic bacteria Wolbachia, which reduces its ability to transmit arboviruses. The breeding of mosquitoes carrying the bacterium Wolbachia in the laboratories of the Institut Pasteur of New Caledonia requires the use of human blood samples for mosquito gorging. The objective of the research is to generate, maintain and amplify Aedes aegypti Caledonian lineages carrying the Wolbachia bacteria for the planned insect release program in Noumea.

Detailed description

The dengue, Zika and chikungunya arboviruses represent potentially severe infections to which the New Caledonian population is exposed. In the absence of specific treatment or vaccine, disease vector control remains the method of choice to limit their spread. However, the traditional methods of prevention and disease vector control must today face their limits: mosquito resistance to insecticides, difficulty of access and destruction of breeding areas... The World Mosquito Program Noumea project is based on the artificial colonization of the mosquito vector Aedes aegypti by the endosymbiotic bacterium Wolbachia, which reduces its ability to transmit arboviruses. The breeding of mosquitoes carrying the bacterium Wolbachia in the laboratories of the Institut Pasteur of New Caledonia requires the use of human blood samples for mosquito gorging. The objective of the research is to generate, maintain and amplify Aedes aegypti Caledonian lineages carrying the bacterium Wolbachia for the planned insect release program in Noumea. The establishment of Wolbachia in Aedes aegypti populations in Noumea should lead to the reduction of active transmission of dengue, Zika and chikungunya in the municipality.

Conditions

Interventions

TypeNameDescription
OTHERBlood donations of hemochromatosis or polycythemia patientsBlood samples are from blood donations of hemochromatosis or polycythemia patients requiring therapeutic bleeding that are not used in medical applications.
OTHERBlood donations of healthy donorsBlood samples are from blood donations of healthy donors.

Timeline

Start date
2018-06-25
Primary completion
2023-06-01
Completion
2023-06-01
First posted
2018-06-11
Last updated
2022-02-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03552094. Inclusion in this directory is not an endorsement.